{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:55:30Z","timestamp":1789505730092,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The S&T Program of Hebei","award":["20377783D"],"award-info":[{"award-number":["20377783D"]}]},{"name":"Medical Science Research Project of Hebei","award":["20221342"],"award-info":[{"award-number":["20221342"]}]},{"name":"Medical Science Research Project of Hebei","award":["20230863"],"award-info":[{"award-number":["20230863"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-025-00979-6","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:52:21Z","timestamp":1767419541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contrast-enhanced mammography based quantitative and qualitative feature analysis across different breast cancer molecular subtypes"],"prefix":"10.1186","volume":"26","author":[{"given":"Yong","family":"Ping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiLun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/phys.2017.00915","volume":"8","author":"SA de Alcala-Corona","year":"2017","unstructured":"de Alcala-Corona SA, Espinal-Enriquez J, et al. Network modularity in BC molecular subtypes[J]. Front Physiol. 2017;8:915. https:\/\/doi.org\/10.3389\/phys.2017.00915.","journal-title":"Front Physiol"},{"key":"979_CR2","doi-asserted-by":"publisher","unstructured":"Savas P, Salgado R, Denkert C, et al. Clinical relevance of host immunity in BC: from TILs to the clinic[J]. Nat Rev Clin Oncol. 2016;13(4):228\u201341. https:\/\/doi.org\/10.1038\/nrclinonc.2015.215.","DOI":"10.1038\/nrclinonc.2015.215"},{"key":"979_CR3","doi-asserted-by":"publisher","unstructured":"Bianchini G, Balko JM, Mayer IA, et al. Triple-negative BC: challenges and opportunities of a heterogeneous disease[J]. Nat Rev Clin Oncol. 2016;13(11):674\u201390. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66.","DOI":"10.1038\/nrclinonc.2016.66"},{"key":"979_CR4","doi-asserted-by":"crossref","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S. Tumour-infiltrating lymphocytes and prognosis in different subtypes of BC: a pooled analysis of 3771 patients treated with neoadjuvant therapy[J]. Lancet Oncol. 2018;19(1):40\u201350. https:\/\/pubmed.ncbi.nlm.nih.gov\/29233559\/.","DOI":"10.1016\/S1470-2045(17)30904-X"},{"key":"979_CR5","volume-title":"ACR BI-RADS contrast enhanced mammography (A supplement to ACR BI-RADS mammography 2013)","author":"CH Lee","year":"2022","unstructured":"Lee CH, Phillips J, Sung JS, Lewin JM, Newell MS. ACR BI-RADS contrast enhanced mammography (A supplement to ACR BI-RADS mammography 2013). Reston, VA: American College of Radiology; 2022."},{"key":"979_CR6","doi-asserted-by":"publisher","unstructured":"He Y, Xu G, Ren J, et al. The application of breast DCE-MRI combined with time signal curve in diagnosing early breast cancer. Chin-Ger J Clin Oncol. 2013;12. https:\/\/doi.org\/10.1007\/s10330-012-1119-1.","DOI":"10.1007\/s10330-012-1119-1"},{"key":"979_CR7","doi-asserted-by":"publisher","unstructured":"Yang SN, Li FJ, Chen JM, et al. Kinetic curve type assessment for classification of breast lesions using dynamic contrast-enhanced MR imaging. PLoS One. 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0152827.","DOI":"10.1371\/journal.pone.0152827"},{"issue":"2","key":"979_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/RLI.0b013e31827d29cf","volume":"48","author":"DM Renz","year":"2013","unstructured":"Renz DM, Diekmann F, Schmitzberger FF, et al. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time. INVEST RADIOL. 2013;48(2):69\u201378. https:\/\/doi.org\/10.1097\/RLI.0b013e31827d29cf.","journal-title":"INVEST RADIOL"},{"issue":"6","key":"979_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1043\/1543-2165-134.6.907","volume":"134","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, et al. American society of clinical oncology\/college of American pathologists guideline recommendations for immunohistochemical testing of Estrogen and progesterone receptors in BC[J]. Arch Pathol Lab Med. 2010;134(6):907\u201322. https:\/\/doi.org\/10.1043\/1543-2165-134.6.907.","journal-title":"Arch Pathol Lab Med"},{"key":"979_CR10","doi-asserted-by":"publisher","unstructured":"Curigliano G, Burstein HJ, Winer EP, et al. De-escalating and escalating treatments for early-stage BC: the St. Gallen International Expert Consensus Conference on the primary therapy of early BC 2017[J]. Ann Oncol. 2019;30(7):1181. https:\/\/doi.org\/10.1093\/annonc\/mdy537.","DOI":"10.1093\/annonc\/mdy537"},{"issue":"4","key":"979_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10916-019-1197-5","volume":"43","author":"C Yuan","year":"2019","unstructured":"Yuan C, Jin F, Guo X, et al. Correlation analysis of BC DWI combined with DCE-MRI imaging features with molecular subtypes and prognostic factors[J]. J Med Syst. 2019;43(4):83. https:\/\/doi.org\/10.1007\/s10916-019-1197-5.","journal-title":"J Med Syst"},{"issue":"4","key":"979_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/jmri.25661","volume":"46","author":"J Wu","year":"2017","unstructured":"Wu J, Sun X, Wang J, et al. Identifying relations between imaging phenotypes and molecular subtypes of BC: model discovery and external validation[J]. J Magn Reson Imaging. 2017;46(4):1017\u201327. https:\/\/doi.org\/10.1002\/jmri.25661.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"979_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/tbi.12799","volume":"23","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ, Zhang J, Baker JA, et al. Relationships between MRI breast imaging-reporting and data system (BI-RADS) lexicon descriptors AndBC molecular subtypes: internal enhancement is associated with luminal B subtype[J]. Breast J. 2017;23(5):579\u201382. https:\/\/doi.org\/10.1111\/tbi.12799.","journal-title":"Breast J"},{"key":"979_CR14","doi-asserted-by":"publisher","unstructured":"Gelardi F, Ragaini EM, Sollini M, et al. Contrast-enhanced mammography versus breast magnetic resonance imaging: a systematic review and meta-analysis. Diagnostics (Basel). 2022;12(8). https:\/\/doi.org\/10.3390\/diagnostics12081890.","DOI":"10.3390\/diagnostics12081890"},{"issue":"4","key":"979_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4048\/jbc.2018.21.e62","volume":"21","author":"EY Kim","year":"2018","unstructured":"Kim EY, Youn I, Lee KH, et al. Diagnostic value of Contrast-Enhanced digital mammography versus Contrast-Enhanced magnetic resonance imaging for the preoperative evaluation of breast cancer. J BREAST CANCER. 2018;21(4):453\u201362. https:\/\/doi.org\/10.4048\/jbc.2018.21.e62.","journal-title":"J BREAST CANCER"},{"issue":"7","key":"979_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1007\/s00330-016-4650-6","volume":"27","author":"EM Fallenberg","year":"2017","unstructured":"Fallenberg EM, Schmitzberger FF, Amer H, et al. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation. EUR RADIOL. 2017;27(7):2752\u201364. https:\/\/doi.org\/10.1007\/s00330-016-4650-6.","journal-title":"EUR RADIOL"},{"issue":"1","key":"979_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/BD-210034","volume":"41","author":"Z Shahraki","year":"2022","unstructured":"Shahraki Z, Ghaffari M, Nakhaie Moghadam M, et al. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis. Breast Dis. 2022;41(1):303\u201315. https:\/\/doi.org\/10.3233\/BD-210034.","journal-title":"Breast Dis"},{"issue":"3","key":"979_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0284185114524197","volume":"56","author":"MS Bae","year":"2015","unstructured":"Bae MS, Seo M, Kim KG, et al. Quantitative MRI morphology of invasive bc:correlation with immunohistochemical biomarkers and subtypes[J]. Acta Radiol. 2015;56(3):269\u201375. https:\/\/doi.org\/10.1177\/0284185114524197.","journal-title":"Acta Radiol"},{"key":"979_CR19","doi-asserted-by":"publisher","unstructured":"Matsuda M, Tsuda T, Ebihara R, et al. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: a comparison with non-triple-negative breast carcinoma. Eur J Radiol. 2021;142. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109838.","DOI":"10.1016\/j.ejrad.2021.109838"},{"key":"979_CR20","doi-asserted-by":"publisher","unstructured":"Li N, Gong W, Xie Y, et al. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer. Breast. 2023;72. https:\/\/doi.org\/10.1016\/j.breast.2023.103595.","DOI":"10.1016\/j.breast.2023.103595"},{"key":"979_CR21","doi-asserted-by":"publisher","unstructured":"Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2015.0030.","DOI":"10.7497\/j.issn.2095-3941.2015.0030"},{"key":"979_CR22","doi-asserted-by":"publisher","unstructured":"Kandula M, Ch KK, Ys AR. Molecular mechanism and targeted therapy options of triple-negative (ER, PgR, HER-2\/neu) breast cancer: review. World J Oncol. 2013;4. https:\/\/doi.org\/10.4021\/wjon681e.","DOI":"10.4021\/wjon681e"},{"key":"979_CR23","doi-asserted-by":"publisher","unstructured":"Zhao S, Zhang X, Zhong H, et al. Background parenchymal enhancement on contrast-enhanced spectral mammography: influence of age, breast density, menstruation status, and menstrual cycle timing. Sci Rep. 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-65526-8.","DOI":"10.1038\/s41598-020-65526-8"},{"key":"979_CR24","doi-asserted-by":"publisher","unstructured":"Ma Y, Liu A, Zhang Y, et al. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI. Eur Radiol. 2022;32. https:\/\/doi.org\/10.1007\/s00330-022-08699-2.","DOI":"10.1007\/s00330-022-08699-2"},{"key":"979_CR25","doi-asserted-by":"publisher","unstructured":"Kawashima H, Inokuchi M, Furukawa H, et al. Magnetic resonance imaging features of BC according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects[J]. SpringerPlus. 2014;3:240. https:\/\/doi.org\/10.1186\/2193-1801-3-240.","DOI":"10.1186\/2193-1801-3-240"},{"key":"979_CR26","doi-asserted-by":"publisher","unstructured":"Yetkin D\u0130, Akp\u0131nar MG, Durhan G, et al. Comparison of clinical and magnetic resonance imaging findings of triple-negative breast cancer with non-triple-negative tumours. Pol J Radiol. 2021;86. https:\/\/doi.org\/10.5114\/pjr.2021.106137.","DOI":"10.5114\/pjr.2021.106137"},{"key":"979_CR27","doi-asserted-by":"publisher","unstructured":"Navarro VL, Alandete GS, Medina GR, et al. MR imaging findings in molecular subtypes of breast cater according to BI-RADS system[J]. Breast J. 2017;23(4):421\u20138. https:\/\/doi.org\/10.1111\/tbj.12756.","DOI":"10.1111\/tbj.12756"},{"key":"979_CR28","doi-asserted-by":"publisher","unstructured":"Clemenceau A, Michou L, Diorio C, et al. Breast cancer and microcalcifications: an osteoimmunological disorder? Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21228613.","DOI":"10.3390\/ijms21228613"},{"key":"979_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1055\/s-0032-1313102","volume":"184","author":"M Rominger","year":"2012","unstructured":"Rominger M, Wisgickl C, Timmesfeld N. Breast microcalcifications as type descriptors to stratify risk of malignancy: A systematic review and Meta-Analysis of 10665 cases with special focus on Round\/Punctate microcalcifications. Fortschr R\u00f6ntgenstr. 2012;184:1144\u201352.","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"979_CR30","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1245\/s10434-014-4362-6","volume":"22","author":"S-Y Kim","year":"2015","unstructured":"Kim S-Y, Kim HY, Kim E-K, Kim MJ, Moon HJ, Yoon JH. Evaluation of malignancy risk stratification of microcalcifications detected on mammography: A study based on the 5th edition of BI-RADS. Ann Surg Oncol. 2015;22:2895\u2013901.","journal-title":"Ann Surg Oncol"},{"key":"979_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12885-015-1312-z","volume":"15","author":"M Naseem","year":"2015","unstructured":"Naseem M, Murray J, Hilton JF, Karamchandani J, Muradali D, Faragalla H, Polenz C, Han D, Bell DC, Brezden-Masley C. Mammographic microcalcifications and breast cancer tumorigenesis:a radiologic-pathologic analysis. BMC Cancer. 2015;15:307.","journal-title":"BMC Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00979-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:19:30Z","timestamp":1770041970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-025-00979-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00979-6","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Ethics Committee of The Fourth Hospital of Hebei Medical University. Informed consent was obtained from all the participants. All methods were carried out in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}